For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220503:nRSC9517Ja&default-theme=true
RNS Number : 9517J EKF Diagnostics Holdings PLC 03 May 2022
EKF Diagnostics Holdings plc
("EKF" or the "Company")
PDMR/Director Dealings
& Holding(s) in Company
EKF, the AIM-listed global diagnostics business, announces that the Board of
EKF has been informed that on Thursday 28 April 2022, certain funds connected
to Christopher Mills, Non-executive Chairman, purchased a total of 1,275,000
ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price
of 35 pence per Ordinary Share.
Following this transaction, Christopher Mills' total direct and indirect
interest in the Company is 132,150,000 Ordinary Shares, representing
approximately 29.04% of the total voting rights over the Company's issued
share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out
below as is the Standard form for notification of major holdings received by
EKF today.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name
Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, (the
"Investment Managers")
2 Reason for the notification
a) Position/status Christopher Mills is the non-executive Chairman of the issuer and Chief
Executive of the Investment Managers
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name EKF Diagnostics Holdings plc
b) LEI 213800DXTF3EAUK1AR05
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code GB0031509804
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
0.35 1,275,000
d) Aggregated information
- Aggregated volume N/A single transaction
- Price
e) Date of the transaction 28 April 2022
f) Place of the transaction London Stock Exchange, AIMX
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the
FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the underlying issuer of existing shares to EKF DIAGNOSTICS HOLDINGS PLC
which voting rights are attached (ii):
1b. Please indicate if the issuer is a non-UK issuer (please mark with an
"X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with
an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) (iii):
3. Details of person subject to the notification obligation (iv)
Name Harwood Capital Investment Management
(Gibraltar) Limited
City and country of registered office (if applicable) Gibraltar
4. Full name of shareholder(s) (if different from 3.) (v)
Name Harwood Capital LLP
North Atlantic Smaller Companies Investment Trust Plc
Oryx International Growth Fund Limited
City and country of registered office (if applicable) London, United Kingdom
London, United Kingdom
Guernsey, Guernsey
5. Date on which the threshold was crossed or reached (vi): 28/04/2022
6. Date on which issuer notified (DD/MM/YYYY): 29/04/2022
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments Total of both in % (8.A + 8.B) Total number of voting rights held in issuer (8.A + 8.B) (vii)
(total of 8.B 1 + 8.B 2)
Resulting situation on the date on which threshold was crossed or reached 29.04 0.00 29.04 132,150,000
Position of previous notification (if 28.76 0.00 28.76
applicable)
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights (ix) % of voting rights
shares
ISIN code (if possible)
Direct Indirect Direct Indirect
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
GB0031509804 150,000 0.03
GB0031509804 96,000,000 21.10
GB0031509804 36,000,000 7.91
SUBTOTAL 8. A 132,150,000 29.04%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument Expiration Exercise/ Number of voting rights that may be acquired if the instrument is % of voting rights
date (x)
Conversion Period (xi)
exercised/converted.
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R
(1) (b)
Type of financial instrument Expiration Exercise/ Physical or cash Number of voting rights % of voting rights
date (x)
Conversion Period (xi)
Settlement (xii)
SUBTOTAL 8.B.2
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural
person or legal entity and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights and/or X
the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (please add additional rows as
necessary) (xiv)
Name (xv) % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher Total of both if it equals or is higher than the notifiable threshold
than the notifiable threshold
Christopher Harwood Bernard Mills (Harwood Capital LLP) 0.03
Christopher Harwood Bernard Mills (North Atlantic Smaller Companies Investment 21.10
Trust plc)
Christopher Harwood Bernard Mills (Oryx International Growth Fund Limited) 7.91
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information (xvi)
Place of completion London Stock Exchange
Date of completion 28 April 2022
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBLGDSGXDDGDC